Kaliumlosartanhydrochloorthiazide Eg (Eurogenerics)

Losartan potassium, the active ingredient in Kaliumlosartanhydrochloorthiazide Eg, is an angiotensin II receptor blocker presented as a combination tablet for oral use. It treats hypertension, often together with hydrochlorothiazide, in adult patients.

GNH USA supplies Kaliumlosartanhydrochloorthiazide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaliumlosartanhydrochloorthiazide Eg acts on the renin‑angiotensin‑aldosterone system and renal sodium handling to lower blood pressure. - Hypertension: provides effective blood‑pressure control in adults. - Diabetic nephropathy: helps slow progression of kidney damage associated with diabetes. - Heart failure with reduced ejection fraction: reduces afterload and improves symptoms when combined with standard therapy.

Kaliumlosartanhydrochloorthiazide Eg may cause a range of adverse reactions.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate intensity. - Fatigue: general tiredness or lack of energy. - Increased urination: due to the diuretic component. - Electrolyte imbalance: especially low potassium levels. - Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue or throat. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: elevated blood potassium concentrations. - Severe dehydration: excessive fluid loss. - Hepatic injury: abnormal liver enzyme elevations. - Blood dyscrasias: rare blood cell abnormalities such as agranulocytosis.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for safety. - Monitor electrolytes: check potassium and sodium levels regularly. - Assess renal function: evaluate kidney function before and during treatment. - Avoid in severe hepatic impairment: use with caution or consider alternatives. - Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare provider. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Kaliumlosartanhydrochloorthiazide Eg can interact with several drug classes.

Major Interactions (Avoid): - Potassium‑sparing diuretics: may cause dangerous hyperkalemia. - ACE inhibitors or ARBs combined with aliskiren in diabetic patients: increased risk of renal dysfunction. - Lithium: concomitant use can raise lithium concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect and affect renal function. - CYP2C9 inhibitors (e.g., fluconazole): can increase losartan plasma levels. - Additional thiazide diuretics or antihypertensives: additive blood‑pressure lowering may require dose adjustment.